Home > Insider Trading > Filing (0000950170-24-081567)

Filing Details

Accession Number:: 0000950170-24-081567
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-07-03 16:30:05
Reporting Period:: 2024-07-01

Accepted Time:: 2024-07-03 16:30:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1756262	Transmedics Group Inc.	TMDX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1430462	I Tamer Khayal	C/O Transmedics Group, Inc. 200 Minuteman Road Andover MA 01810	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-07-01	1,458	$38.46	22,301	No	4	M	Direct
Common Stock	Acquisiton	2024-07-01	417	$66.10	22,718	No	4	M	Direct
Common Stock	Acquisiton	2024-07-01	1,083	$13.28	23,801	No	4	M	Direct
Common Stock	Disposition	2024-07-01	110	$149.57	23,691	No	4	S	Direct
Common Stock	Disposition	2024-07-01	1,000	$150.70	22,691	No	4	S	Direct
Common Stock	Disposition	2024-07-01	1,106	$151.33	21,585	No	4	S	Direct
Common Stock	Disposition	2024-07-01	582	$152.53	21,003	No	4	S	Direct
Common Stock	Disposition	2024-07-01	160	$153.48	20,843	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-07-01	1,458	$0.00	1,458	$38.46
Common Stock	Stock Option (Right to Buy)	Disposition	2024-07-01	417	$0.00	417	$66.10
Common Stock	Stock Option (Right to Buy)	Disposition	2024-07-01	1,083	$0.00	1,083	$13.28

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,667	2031-02-24	No	4	M	Direct
13,349	2033-02-20	No	4	M	Direct
21,667	2032-02-22	No	4	M	Direct

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $149.00 to $149.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.00 to $150.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.00 to $151.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $152.00 to $152.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $153.04 to $153.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 20, 2027.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.